122 related articles for article (PubMed ID: 6288701)
41. gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
Hawiger J; Timmons S; Kloczewiak M; Strong DD; Doolittle RF
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2068-71. PubMed ID: 6281794
[TBL] [Abstract][Full Text] [Related]
42. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123).
Kornecki E; Lee H; Merlin F; Hershock D; Tuszynski GP; Niewiarowski S
Thromb Res; 1984 Apr; 34(1):35-49. PubMed ID: 6328693
[TBL] [Abstract][Full Text] [Related]
43. Platelet aggregation by fibrinogen polymers crosslinked across the E domain.
McManama G; Lindon JN; Kloczewiak M; Smith MA; Ware JA; Hawiger J; Merrill EW; Salzman EW
Blood; 1986 Aug; 68(2):363-71. PubMed ID: 3730607
[TBL] [Abstract][Full Text] [Related]
44. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets.
Kornecki E; Niewiarowski S; Morinelli TA; Kloczewiak M
J Biol Chem; 1981 Jun; 256(11):5696-701. PubMed ID: 6263888
[No Abstract] [Full Text] [Related]
45. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
[TBL] [Abstract][Full Text] [Related]
46. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
Bennett JS; Vilaire G; Burch JW
J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
[TBL] [Abstract][Full Text] [Related]
47. Fibrinogen interaction with platelet receptors.
Niewiarowski S; Kornecki E; Budzynski AZ; Morinelli TA; Tuszynski GP
Ann N Y Acad Sci; 1983 Jun; 408():536-55. PubMed ID: 6307105
[TBL] [Abstract][Full Text] [Related]
48. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.
Kornecki E; Tuszynski GP; Niewiarowski S
Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105
[TBL] [Abstract][Full Text] [Related]
49. Tissue plasminogen activator promotes platelet disaggregation in plasma.
Loscalzo J; Vaughan DE
J Clin Invest; 1987 Jun; 79(6):1749-55. PubMed ID: 2438305
[TBL] [Abstract][Full Text] [Related]
50. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
[TBL] [Abstract][Full Text] [Related]
51. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
[TBL] [Abstract][Full Text] [Related]
52. Anti-fibrinogen antibody mediates fibrinogen binding to platelet membrane glycoprotein IIb-IIIa.
Mohri H; Tanabe J; Fujita H; Kanamori H; Ohkubo T
Br J Haematol; 1993 Oct; 85(2):341-7. PubMed ID: 8280606
[TBL] [Abstract][Full Text] [Related]
53. Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo I as compared with normal fibrinogen.
Thorsen LI; Brosstad F; Solum NO; Stormorken H
Scand J Haematol; 1986 Feb; 36(2):203-10. PubMed ID: 3010440
[TBL] [Abstract][Full Text] [Related]
54. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
55. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
56. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of fibrin(ogen) binding to stimulated platelets by a monoclonal antibody specific for a conformational determinant of GPIIIa.
Ramsamooj P; Doellgast GJ; Hantgan RR
Thromb Res; 1990 Jun; 58(6):577-92. PubMed ID: 2385828
[TBL] [Abstract][Full Text] [Related]
58. Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation.
Niewiarowski S; Budzynski AZ; Lipinski B
Blood; 1977 Apr; 49(4):635-44. PubMed ID: 843621
[TBL] [Abstract][Full Text] [Related]
59. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
Peerschke EI
Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
[TBL] [Abstract][Full Text] [Related]
60. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
